| General Information of Drug Metabolite (DM) (ID: DM019270) |
| DM Name |
Monodemethylated telapristone
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A5 (CYP3A5)
|
DME0012
|
| Oxidation - Demethylation |
Telapristone
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A5 (CYP3A5)
|
DME0012
|
| Oxidation - Demethylation |
Telapristone
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Telapristone |
DR3284
|
Phase 2 |
Endometriosis |
|
|
| References |
| 1 |
Population pharmacokinetics of telapristone (CDB-4124) and its active monodemethylated metabolite CDB-4453, with a mixture model for total clearance
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
